Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC

NCT04951063 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Lung Carcinoma

Interventions

RADIATION: Hypofractionated radiotherapy
DRUG: Concurrent chemotherapy
DRUG: Consolidation immunotherapy

Sponsor

Sun Yat-sen University